LB's Mona's comments
IBI Q3/16 Results: EBITDA In Line with Estimates, EPS Beat, Taking up TP to $8.00
IBI Group Inc. (IBG-T)
Rating: Buy – Target: $8.00 Price: $6.26
Mona Nazir, MBA, Analyst (NazirM@lb-securities.ca; 514-350-2964)
Impact: Slightly positive.
Revenue and EBITDA in line, EPS beat.
Following strong Q2/16 results, IBI showed continuing momentum in Q3/16 with the highest organic growth in our engineering coverage universe. Management maintained their 2016 guidance at $350M.
Revenue for Q3 came in at $88.2M (up 5.3% YoY) compared to $83.8M in Q3/15 and our $87.1M estimate.
Adj. EBITDA of $10.2M in line our / consensus estimate of $10.1M. Margins of 11.6% (in line with our forecast) illustrated a 30 bps improvement YoY and came at the higher end of management’s targeted range of 8-12%.
We reiterate our Buy rating while our TP increases to $8.00, from $7.00 previously.